Related Experiment Videos
Blood conservation with membrane oxygenators and dipyridamole
The Annals of Thoracic Surgery
|July 1, 1987
Summary
Using a membrane oxygenator with dipyridamole significantly preserves platelets and reduces bleeding during coronary artery bypass grafting surgery, offering optimal blood conservation.
Area of Science:
- Cardiovascular Surgery
- Hematology
- Biomedical Engineering
Background:
- Cardiopulmonary bypass (CPB) can activate and deplete platelets, potentially leading to increased postoperative bleeding.
- Platelet dysfunction and reduced counts post-CPB are significant concerns in cardiac surgery.
- Both oxygenator type and perioperative medications can influence platelet behavior during CPB.
Purpose of the Study:
- To evaluate the impact of a membrane oxygenator versus a bubble oxygenator on platelet preservation and postoperative bleeding.
- To assess the efficacy of the antiplatelet agent dipyridamole in protecting platelets during CPB and reducing bleeding.
- To determine the combined effect of membrane oxygenators and dipyridamole on platelet counts and blood loss in coronary artery bypass grafting (CABG).
Main Methods:
- A prospective randomized trial involving 44 patients undergoing elective CABG.
- Comparison of four groups: bubble oxygenator with/without dipyridamole, and membrane oxygenator with/without dipyridamole.
- Measurement of platelet counts, platelet activation markers (thromboxane B2, platelet factor 4), and postoperative blood loss.
Main Results:
- Patients receiving a bubble oxygenator without dipyridamole had the lowest platelet counts and highest blood loss.
- The combination of a membrane oxygenator and dipyridamole resulted in the highest platelet counts and least blood loss (p < .05).
- Both membrane oxygenators and dipyridamole independently contributed to platelet preservation, as shown by multivariate analysis.
Conclusions:
- A membrane oxygenator combined with dipyridamole provides optimal platelet preservation and blood conservation during CABG.
- Both the type of oxygenator and the use of dipyridamole are crucial factors in mitigating CPB-induced platelet dysfunction and bleeding.
- These findings support the use of membrane oxygenators and dipyridamole for improved patient outcomes in cardiac surgery.